Developer of a non-invasive single treatment therapy designed to address the problem of Myopia. The company's therapy is assisted by Corneal Crosslinking Lens that is comfortable and may be worn with the eye open or closed and has a real-time ultrasound sensing for accurate prescription tuning, enabling eye specialists to assure Myopia treatment in a faster, secure and cost effective manner.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Angel (individual) | 06-Feb-2019 | $200K | 00.000 | Completed | Startup | |
2. Angel (individual) | 02-Jun-2017 | 00.000 | 00.000 | Completed | Startup | |
1. Angel (individual) | 01-Jan-2014 | Completed | Startup |
Name | Representing | Role | Since |
---|---|---|---|
Roy Chuck Ph.D | TECLens | Co-Founder & Chairman of Medical Advisory Board | 000 0000 |